
YugaCell enables researchers to understand how cells respond to treatments through deep molecular profiling and AI. They apply multiomics and single-cell technologies, immune repertoire profiling, and bioinformatics to analyze samples and guide experiment design. Their methods support R&D and clinical trials, with emphasis on statistical rigor and clinical validation to avoid vendor lock-in. Core tech includes single-cell sequencing, spatial transcriptomics, V(D)J sequencing, and AI/statistics for data interpretation. The company targets biopharma, CROs, and research labs seeking precise cellular insights at scale.

YugaCell enables researchers to understand how cells respond to treatments through deep molecular profiling and AI. They apply multiomics and single-cell technologies, immune repertoire profiling, and bioinformatics to analyze samples and guide experiment design. Their methods support R&D and clinical trials, with emphasis on statistical rigor and clinical validation to avoid vendor lock-in. Core tech includes single-cell sequencing, spatial transcriptomics, V(D)J sequencing, and AI/statistics for data interpretation. The company targets biopharma, CROs, and research labs seeking precise cellular insights at scale.